ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kneat Recognised as Leader in G2 Pharma and Biotech Fall 2025 Grid Reports

By: Newsfile

Score based on User Satisfaction and Market Presence significantly exceeds peers

Limerick, Ireland--(Newsfile Corp. - September 24, 2025) - kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, has been awarded the top position in three of G2 Software Review's Fall 2025 Pharma and Biotech Software category reports. Kneat was recognized as:

Kneat achieved a total G2 Satisfaction Score of 98 out of 100, 20 points higher than the second-ranked company's score of 78.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11876/267637_kneatimg1_550.jpg

Grid from Fall 2025 G2 Grid® Report for Pharma and Biotech

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11876/267637_kneatimg1.jpg

"Earning three G2 leader badges is no small feat for a software company supporting any industry, let alone one as demanding and precise as life sciences," said Eddie Ryan, CEO of Kneat. "The achievement reflects not only the trust that our customers place in us, but the dedication of our team to deliver Kneat's pioneering user-focused software. At Kneat, customer satisfaction isn't just a value — it's at the heart of everything we do. I am proud of our team for embracing this mission every single day."

Kneat's top rating in the G2 Pharma and Biotech Relationship Index is based on customer feedback across categories "Ease of Doing Business," "Likely to Recommend," and "Quality of Support." Kneat was also rated 2nd overall in the G2 Pharma and Biotech Usability Index measuring customer feedback on "Ease of Admin," "Ease of Use" and "Meets Requirements."

G2 scores are based on validated reviews from industry professionals utilising factors such as a company's review count, web presence, growth, influence and engagement. As the largest and most trusted software marketplace, G2 offers 100% validated reviews that more than a million professionals annually — including employees at all Fortune 500 companies — rely on to make informed decisions about their software purchases.

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. compliance standard. Independent customer studies have shown Kneat Gx to reduce labor hours associated with validation documentation by more than 50%, accelerate review and approval cycles by up to 50%, and consistently support higher standards of regulatory compliance. For more information visit www.kneat.com.

For further information:

Katie Keita, Kneat Investor Relations
P: + 1 902-450-2660
E: investors@kneat.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267637

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.